Jocelin Huang

468 total citations
13 papers, 226 citations indexed

About

Jocelin Huang is a scholar working on Genetics, Hematology and Surgery. According to data from OpenAlex, Jocelin Huang has authored 13 papers receiving a total of 226 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 7 papers in Hematology and 1 paper in Surgery. Recurrent topics in Jocelin Huang's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Acute Myeloid Leukemia Research (4 papers). Jocelin Huang is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Acute Myeloid Leukemia Research (4 papers). Jocelin Huang collaborates with scholars based in United States, Poland and Italy. Jocelin Huang's co-authors include Ayalew Tefferi, Animesh Pardanani, Ruben A. Mesa, Curtis A. Hanson, Chin‐Yang Li, Susan M. Schwager, Wenting Wu, Kebede Hussein, Chin‐Yang Li and Aminah Jatoi and has published in prestigious journals such as Blood, Cancer and Mayo Clinic Proceedings.

In The Last Decade

Jocelin Huang

11 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jocelin Huang United States 8 200 171 104 73 14 13 226
Gaëlle Vertenoeil Belgium 4 216 1.1× 184 1.1× 136 1.3× 55 0.8× 4 0.3× 7 247
Francesca Giacobbi Italy 6 82 0.4× 75 0.4× 61 0.6× 50 0.7× 9 0.6× 12 162
Elisa Rumi Italy 6 428 2.1× 323 1.9× 267 2.6× 140 1.9× 7 0.5× 10 443
Miklós Egyed Hungary 7 156 0.8× 100 0.6× 94 0.9× 51 0.7× 25 1.8× 23 171
Blanka Kubešová Czechia 3 245 1.2× 191 1.1× 142 1.4× 88 1.2× 8 0.6× 6 257
Benedetta Sordi Italy 4 140 0.7× 118 0.7× 78 0.8× 54 0.7× 10 0.7× 9 169
Denise Wolleschak Germany 9 86 0.4× 85 0.5× 84 0.8× 35 0.5× 5 0.4× 25 157
Badr Kilani France 5 104 0.5× 82 0.5× 66 0.6× 60 0.8× 2 0.1× 7 157
Jun Imagawa Japan 7 85 0.4× 148 0.9× 109 1.0× 13 0.2× 6 0.4× 9 181
Faye Feller United States 7 97 0.5× 124 0.7× 110 1.1× 24 0.3× 6 0.4× 25 187

Countries citing papers authored by Jocelin Huang

Since Specialization
Citations

This map shows the geographic impact of Jocelin Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelin Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelin Huang more than expected).

Fields of papers citing papers by Jocelin Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jocelin Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelin Huang. The network helps show where Jocelin Huang may publish in the future.

Co-authorship network of co-authors of Jocelin Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Jocelin Huang. A scholar is included among the top collaborators of Jocelin Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jocelin Huang. Jocelin Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Danhauer, Suzanne C., Emily V. Dressler, W. Mark Brown, et al.. (2023). Reducing Anxiety and Dyspnea via Device-Guided Breathing (RELAX): A Multi-Site Feasibility Study in Post-Treatment Lung Cancer Survivors at Community Cancer Clinics (WF-01213). Integrative Cancer Therapies. 22. 1563479542–1563479542.
3.
Vaidya, Rakhee, Sergio Siragusa, Jocelin Huang, et al.. (2009). Mature Survival Data for 176 Patients Younger Than 60 Years With Primary Myelofibrosis Diagnosed Between 1976 and 2005: Evidence for Survival Gains in Recent Years. Mayo Clinic Proceedings. 84(12). 1114–1119. 11 indexed citations
4.
Huang, Jocelin & Aminah Jatoi. (2009). Morbidity and Mortality in Patients with Cancer who Become Nonambulatory after Spinal Cord Compression: A Case Series on End-of-Life Care. Journal of Palliative Medicine. 12(3). 219–222. 9 indexed citations
5.
Mesa, Ruben A., Susan M. Schwager, Jocelin Huang, et al.. (2009). Weight Loss, Splenomegaly, and Hypocholesterolemia in Myeloproliferative Neoplasms: Patterns and Relevance from the Pre JAK2 Inhibitor Era.. Blood. 114(22). 3918–3918. 10 indexed citations
6.
Hussein, Kebede, Jocelin Huang, Terra L. Lasho, et al.. (2009). Karyotype complements the International Prognostic Scoring System for primary myelofibrosis. European Journal Of Haematology. 82(4). 255–259. 34 indexed citations
7.
Huang, Jocelin, Chin‐Yang Li, Ruben A. Mesa, et al.. (2008). Risk factors for leukemic transformation in patients with primary myelofibrosis. Cancer. 112(12). 2726–2732. 84 indexed citations
8.
Mesa, Ruben A., Susan M. Schwager, Jocelin Huang, et al.. (2008). Dynamics, and Prognostic Impact, of Weight Loss in Primary Myelofibrosis. Blood. 112(11). 5224–5224. 4 indexed citations
9.
Tefferi, Ayalew, Jocelin Huang, Susan M. Schwager, et al.. (2007). Validation and comparison of contemporary prognostic models in primary myelofibrosis. Cancer. 109(10). 2083–2088. 48 indexed citations
10.
Huang, Jocelin, Chin‐Yang Li, Ruben A. Mesa, et al.. (2007). Erythropoiesis Stimulating Agents and the Risk of Leukemic Transformation in Primary Myelofibrosis.. Blood. 110(11). 554–554. 5 indexed citations
11.
Sirhan, Shireen, Jocelin Huang, Chin‐Yang Li, & Ayalew Tefferi. (2007). The Presence of the JAK2V617F Mutation in Primary Myelofibrosis and Its Allele Burden in Polycythemia Vera Predict Chemosensitivity to Hydroxyurea.. Blood. 110(11). 3539–3539.
12.
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026